Epofit Recombinant Human Erythropoietin Alfa Injection 6000 IU

Name: Epofit Recombinant Human Erythropoietin Alfa Injection 6000 IU
Brand: K T Agencies
Price: 2750.0 INR
Availability: InStock

Price 2750.0 INR/ Piece

Get a Price/Quote

MOQ : 100 Packs

Epofit Recombinant Human Erythropoietin Alfa Injection 6000 IU Specification

Salt Composition
Recombinant Human Erythropoietin Alfa

Dosage Form
Injection, Prefilled Syringe

Indication
Treatment of anemia due to chronic kidney disease

Enzyme Types
Non-applicable/Protein Therapeutic

Feature
Sterile, pyrogen-free, single-use

Application
Subcutaneous or intravenous administration

Physical Color/Texture
Clear, colorless solution

Fermentation Smell
Odorless

Storage Instructions
Store at 2°C to 8°C. Do not freeze.

Shelf Life
24 months

Volume
1 ml

Strength
6000 IU

Prescription
Required

Product Type
Biological

Container Type
Blister pack

Route
Parenteral

Packaging
Prefilled syringe

Epofit Recombinant Human Erythropoietin Alfa Injection 6000 IU Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
7-10 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Epofit Recombinant Human Erythropoietin Alfa Injection 6000 IU

Take advantage of the immaculate formulation of Epofit Recombinant Human Erythropoietin Alfa Injection 6000 IU, a superlative biological product popularly recognized for treating anemia in chronic kidney disease. Offered by leading exporters and suppliers from India, each sterile, pyrogen-free prefilled syringe presents the paragon of safety and therapeutic efficacy, delivering 6000 IU of recombinant human erythropoietin alfa in a clear, colorless solution. Designed for single-use, Epofit's prescription-only blister pack ensures precise dosing via subcutaneous or intravenous administration. Experience optimal results and superior reliability with this advanced protein therapeutic.

Direction of Use & Competitive Advantages

Epofit Recombinant Human Erythropoietin Alfa Injection 6000 IU is intended for subcutaneous or intravenous injection, ensuring targeted application at the surface of administration. The prefilled, sterile syringe simplifies precise dosage and guarantees safety. Competitive advantages include its pyrogen-free formulation, single-use convenience, and superior efficacy due to stringent manufacturing standards. This biologic's immaculate quality supports optimal patient outcomes and sets a distinguished benchmark in anemia management.

Sample Policy & Export Supply Capacity

Epofit offers transparent sample policies facilitating client valuation before procurement. With robust supply ability, this product caters to diverse logistics requirements and maintains high transport service standards for domestic and international deliveries. Main export markets include Asia and other regions, leveraging efficient regulatory adherence and consistent quality. Epofit's seamless logistics and dependable inventory assure timely supply and exceptional reliability to all importers and distributors globally.

FAQ's of Epofit Recombinant Human Erythropoietin Alfa Injection 6000 IU:

Q: How should Epofit Recombinant Human Erythropoietin Alfa Injection 6000 IU be administered?

A: Epofit should be administered either subcutaneously or intravenously, following the dosage prescribed by your healthcare professional.

Q: What are the benefits of using Epofit for anemia caused by chronic kidney disease?

A: Epofit offers superlative efficacy in increasing red blood cell production, effectively addressing anemia symptoms and improving patient quality of life.

Q: When must Epofit Injection be stored to maintain its effectiveness?

A: Epofit must be stored at 2C to 8C and must not be frozen. Proper storage is essential to preserve its potency and safety.

Q: Where is Epofit Injection primarily exported from?

A: Epofit Injection is supplied by exporters and suppliers based in India, with main export markets throughout Asia and other international regions.

Q: What is the process for obtaining a sample of Epofit Injection?

A: Clients interested in samples may utilize the established sample policy for product valuation before full-scale procurement, coordinated with the provider's logistics team.

Q: How does the prefilled syringe format benefit usage?

A: The prefilled syringe ensures accurate dosing, reduces contamination risk, and simplifies administration, thereby optimizing safety and convenience for healthcare providers.

Tell us about your requirement